Transcriptomics

Dataset Information

0

Epigenetic priming induces cancer testis antigens and human endogenous retroviruses in glioma for enhanced T cell responses at single cell resolution (bulk RNA-Seq)


ABSTRACT: Glioblastoma (GBM) is the most common malignant primary brain tumor and remains incurable. Previous work has shown that systemic administration of Decitabine (DAC) induces sufficient expression of NY-ESO-1 in GBM for targeting by adoptive T-cell therapy in vivo. However, the mechanisms by which DAC enhances immunogenicity in GBM remain to be elucidated. Using patient tissue, immortalized glioma cells, and primary patient-derived gliomaspheres, we demonstrate in vitro that basal NY-ESO-1 expression is restricted by promoter hypermethylation in gliomas. DAC treatment of glioma cells specifically inhibits DNA methylation silencing and renders NY-ESO-1 an inducible tumor antigen. Targeting of DAC-induced NY-ESO-1 in primary GBM cells promotes specific and polyfunctional NY-ESO-1 TCR-T cell responses. DAC further upregulates other tumor-associated cancer testis antigens concomitantly with tumor-intrinsic reactivation of human endogenous retroviruses (hERV) and type I interferon. Overall, we demonstrate that DAC promotes an inducible tumor antigen and enhances T cell functionality against GBM.

ORGANISM(S): Homo sapiens

PROVIDER: GSE261187 | GEO | 2024/06/03

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2024-06-03 | GSE261188 | GEO
2024-06-04 | GSE261190 | GEO
2022-09-09 | GSE213015 | GEO
2013-02-11 | E-GEOD-42922 | biostudies-arrayexpress
2017-05-27 | GSE98995 | GEO
2024-09-30 | GSE254553 | GEO
| 2119578 | ecrin-mdr-crc
2023-05-04 | GSE210578 | GEO
| phs000505 | dbGaP
2022-05-16 | GSE202979 | GEO